FierceBiotechOriginal article
{"a":[{"_":"United Therapeutics pays $140M for thymic cell therapy startup","$":{"href":"/biotech/united-therapeutics-pays-140m-thymic-cell-therapy-startup","hreflang":"en"}}]}
Positive
AI Analysis
Summary
United Therapeutics acquired Thymmune Therapeutics for $140 million to expand its portfolio of preclinical regenerative cell therapies targeting thymic regeneration.
Importance:7/10
Sentiment:
0.30
M&Acell therapyregenerative medicinethymus
Related Companies
Read the original article
Published by FierceBiotech on July 3, 2026 5:50 AM